Thein Anna-Sophie

2 articles in GJC

Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes.

Niazi Siar, Gnesin Filip, Thein Anna-Sophie, Andreasen Jens R, Horwitz Anna, Mouhammad Zaynab A et al.

OphthalmologyMar 202431 citationsCase-Control Study

GLP-1RAs in type 2 diabetics were linked to a lower glaucoma risk, particularly with prolonged use. This suggests a potential neuroprotective role for these drugs.

Full abstract PubMed

Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement.

Thein Anna-Sophie, Hedengran Anne, Azuara-Blanco Augusto, Arita Reiko, Cvenkel Barbara, Gazzard Gus et al.

Am J OphthalmolMay 20228 citationsReview

Experts defined key outcomes (e.g., ocular surface, dryness, quality of life) for consistently assessing glaucoma eye drop side effects in clinical trials, improving future research comparability and patient safety.

Full abstract PubMed

All 2 articles loaded

Global Search

Thein Anna-Sophie

Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes.

Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement.